CHD Chemicals (BSE 539800)₹8.00+0.50%Trading - Chemicals
In the Mar 2026 quarter (standalone), CHD Chemicals reported sales of ₹1.52 Cr, up 4.8% from Mar 2025, and net profit of −₹0.01 Cr, down 116.7% year on year. For the year to Mar 2026, sales were ₹5.24 Cr and net profit −₹0.30 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.44 | 4.64 | 3.83 | 4.31 | 1.51 | 2.07 | 1.88 | 1.45 | 1.26 | 1.12 | 1.31 | 1.52 |
| Expenses | 3.28 | 4.31 | 3.71 | 4.17 | 1.68 | 1.97 | 1.83 | 1.41 | 1.44 | 1.14 | 1.43 | 1.60 |
| Operating Profit | 0.17 | 0.34 | 0.13 | 0.13 | −0.14 | 0.09 | 0.04 | 0.03 | −0.15 | 0.00 | −0.09 | −0.05 |
| OPM % | 5.2% | 7.5% | 3.6% | 3.2% | −9.9% | 4.8% | 2.7% | 2.8% | −12.7% | 0.0% | −7.6% | −4.0% |
| Other Income | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.07 | 0.02 | 0.12 | 0.10 |
| Interest | 0.08 | 0.09 | 0.07 | 0.07 | 0.07 | 0.05 | 0.06 | 0.11 | 0.04 | 0.04 | 0.06 | 0.10 |
| Depreciation | 0.05 | 0.07 | 0.04 | 0.03 | 0.05 | 0.05 | 0.02 | 0.03 | 0.04 | 0.04 | 0.02 | −0.02 |
| Profit before tax | 0.05 | 0.19 | 0.05 | 0.02 | −0.25 | 0.00 | −0.01 | 0.07 | −0.15 | −0.04 | −0.04 | 0.00 |
| Tax % | 33.3% | 19.9% | 33.3% | 33.3% | 61.5% | −1,700.1% | 0.0% | 12.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | 0.04 | 0.14 | 0.03 | 0.01 | −0.41 | 0.17 | −0.01 | 0.06 | −0.14 | −0.04 | −0.04 | −0.01 |
| EPS (Rs) | 0.06 | 0.16 | 0.05 | 0.03 | −0.43 | 0.19 | −0.03 | 0.08 | −0.16 | −0.06 | −0.06 | −0.03 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 40.32 | 42.83 | 34.32 | 75.46 | 85.75 | 68.65 | 31.27 | 19.05 | 16.22 | 6.89 | 5.24 | 5.21 |
| Expenses | 39.82 | 41.97 | 33.94 | 74.17 | 84.68 | 68.21 | 30.53 | 18.49 | 15.45 | 6.87 | 5.60 | 5.61 |
| Operating Profit | 0.65 | 1.00 | 0.51 | 1.48 | 1.32 | 0.67 | 0.82 | 0.62 | 0.80 | 0.02 | −0.32 | −0.29 |
| OPM % | 1.6% | 2.3% | 1.5% | 2.0% | 1.5% | 1.0% | 2.6% | 3.3% | 5.0% | 0.4% | −6.3% | −5.6% |
| Other Income | 0.09 | 0.04 | 0.73 | 0.03 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.20 | 0.34 | 0.31 |
| Interest | 0.26 | 0.38 | 0.36 | 0.36 | 0.37 | 0.39 | 0.48 | 0.38 | 0.29 | 0.26 | 0.21 | 0.24 |
| Depreciation | 0.12 | 0.15 | 0.21 | 0.28 | 0.27 | 0.22 | 0.15 | 0.21 | 0.21 | 0.18 | 0.08 | 0.08 |
| Profit before tax | 0.37 | 0.52 | 0.68 | 0.88 | 0.71 | 0.09 | 0.22 | 0.08 | 0.34 | −0.19 | −0.26 | −0.23 |
| Tax % | 28.9% | 33.9% | 26.0% | 25.8% | 27.7% | 49.9% | −121.8% | 22.2% | 25.7% | 0.0% | 14.7% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.26 | 0.34 | 0.51 | 0.65 | 0.52 | 0.05 | 0.50 | 0.06 | 0.25 | −0.19 | −0.30 | −0.23 |
| EPS (Rs) | 0.53 | 0.55 | 0.60 | 0.66 | 0.53 | 0.07 | 0.51 | 0.08 | 0.27 | −0.21 | −0.32 | −0.31 |
| Dividend payout % | 0.0% | 18.5% | 0.0% | 0.0% | 0.0% | 252.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.40 | 5.19 | 6.42 | 8.83 | 10.07 | 10.08 | 10.07 | 10.08 | 10.08 | 10.08 | 10.08 | 10.10 |
| Reserves | 0.40 | 0.85 | 2.11 | 1.93 | 2.28 | 2.81 | 2.71 | 3.24 | 2.96 | 3.22 | 3.02 | 2.71 |
| Borrowings | 1.93 | 2.09 | 2.66 | 1.02 | 4.08 | 1.88 | 6.25 | 19.81 | 9.14 | 6.64 | 6.75 | 5.80 |
| Other Liabilities | 13.99 | 16.65 | 11.94 | 11.22 | 19.56 | 29.02 | 24.03 | 7.30 | 4.44 | 3.17 | 1.42 | 1.49 |
| Total Liabilities | 19.72 | 24.78 | 23.13 | 23.00 | 35.99 | 43.79 | 43.06 | 40.43 | 26.62 | 23.11 | 21.27 | 20.10 |
| Fixed Assets | 0.50 | 0.33 | 0.50 | 1.41 | 1.23 | 0.94 | 0.76 | 1.07 | 0.91 | 0.70 | 0.52 | 0.57 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 19.22 | 24.45 | 22.63 | 21.59 | 34.76 | 42.85 | 42.30 | 39.36 | 25.71 | 22.41 | 20.75 | 19.53 |
| Inventories | 2.59 | 2.59 | 3.19 | 1.62 | 4.46 | 4.51 | 6.00 | 5.70 | 5.74 | 4.18 | 3.68 | 2.64 |
| Trade receivables | 15.55 | 17.96 | 18.16 | 17.77 | 29.00 | 36.67 | 34.79 | 31.95 | 18.71 | 17.19 | 15.41 | 15.70 |
| Cash & equivalents | 0.49 | 3.24 | 0.52 | 1.24 | 0.52 | 0.53 | 0.62 | 0.55 | 0.60 | 0.54 | 0.50 | 0.03 |
| Total Assets | 19.72 | 24.78 | 23.13 | 23.00 | 35.99 | 43.79 | 43.06 | 40.43 | 26.62 | 23.11 | 21.27 | 20.10 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −2.86 | 0.99 | −4.66 | 0.71 | −2.91 | 2.47 | −3.89 | −12.67 | 11.08 | 2.68 | 0.07 | 0.77 |
| Cash from investing activity | −0.05 | −0.10 | −0.36 | −1.06 | 0.06 | 0.09 | 0.14 | −0.43 | 0.00 | 0.02 | 0.04 | −0.07 |
| Cash from financing activity | 2.92 | 1.85 | 2.28 | 1.08 | 2.11 | −2.54 | 3.81 | 13.01 | −10.98 | −2.77 | −0.12 | −1.14 |
| Net cash flow | 0.00 | 2.74 | −2.72 | 0.71 | −0.71 | 0.00 | 0.08 | −0.06 | 0.04 | −0.05 | −0.04 | −0.46 |
| Capex | 0.02 | 0.12 | 0.26 | 1.08 | 0.02 | 0.03 | 0.03 | 0.48 | 0.07 | 0.02 | 0.02 | 0.28 |
| Free cash flow | −2.89 | 1.10 | −4.92 | −0.38 | −2.92 | 2.52 | −3.92 | −13.19 | 11.06 | 2.69 | 0.06 | 0.64 |
| CFO / OP % | −441.0% | 165.1% | −449.9% | 165.1% | −182.9% | 203.1% | −539.9% | −1,523.0% | 1,768.1% | 344.1% | 200.1% | −230.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 128 | 162 | 155 | 189 | 140 | 156 | 185 | 372 | 358 | 387 | 816 | 1,091 |
| Inventory days | 22 | 24 | 28 | 18 | 22 | 19 | 32 | 70 | 118 | 104 | 219 | 190 |
| Days payable | 120 | 142 | 103 | 104 | 94 | 124 | 129 | 79 | 88 | 70 | 76 | 89 |
| Cash conversion cycle | 32 | 47 | 82 | 104 | 70 | 53 | 90 | 365 | 390 | 423 | 962 | 1,194 |
| Working capital days | 22 | 19 | 62 | 105 | 57 | 53 | 75 | 322 | 339 | 379 | 901 | 1,249 |
| ROCE % | 14.4% | 8.4% | 9.3% | 9.1% | 8.8% | 7.0% | 2.9% | 2.7% | 1.7% | 3.0% | 0.3% | −0.4% |
For the Mar 2026 quarter, CHD Chemicals reported sales of ₹1.52 Cr, up 4.8% year on year and net profit of −₹0.01 Cr, down 116.7% year on year. The operating margin was −4.0%.
CHD Chemicals' sales for the year to Mar 2026 were ₹5.24 Cr; over the last twelve months they were ₹5.21 Cr.
Net profit for the year to Mar 2026 was −₹0.30 Cr, and −₹0.23 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.31.
CHD Chemicals reported borrowings of ₹5.80 Cr at Mar 2026, against cash and equivalents of ₹0.03 Cr.
Cash from operations was ₹0.77 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.64 Cr.